Download Free Assessing The Need For Prison Based Needle Exchange Programs In Canada Book in PDF and EPUB Free Download. You can read online Assessing The Need For Prison Based Needle Exchange Programs In Canada and write the review.

Vols. for 1963- include as pt. 2 of the Jan. issue: Medical subject headings.
The United States has spent two productive decades implementing a variety of prevention programs. While these efforts have slowed the rate of infection, challenges remain. The United States must refocus its efforts to contain the spread of HIV and AIDS in a way that would prevent as many new HIV infections as possible. No Time to Lose presents the Institute of Medicine's framework for a national prevention strategy.
As part of its work, The Expert Committee on Aids in Prisons (ECAP) prepared this Final Report in which it addresses issues that HIV/AIDS & drug use raise in federal correctional institutions & contains recommendations. Analyses issues, such as testing, housing & activities, educational programs preventive measures for inmates, protective measures for staff, health care, women inmates, etc.
This document attempts to present an overview of Canada's current strategy regarding substance abuse issues. The strategy reflects a balance between reducing the supply of drugs and reducing the demand for drugs. Substances involved include alcohol, medications (both prescription and non-prescription), illicit drugs, inhalants, and banned and restricted performance-enhancing drugs as defined by the International Olympic Committee. The document first outlines the basic principles of the strategy, and its goals and objectives (primarily health-related). It then describes the components of the strategy's framework (research, knowledge development and dissemination, prevention programs, treatment and rehabilitation, legislation and enforcement/control, national co-ordination, international co-operation), and reviews future directions and priorities. Appendices include a historical context and a review of the current situation regarding substance use and abuse in Canada.
This edited volume provides the first ever comprehensive, international and multi-disciplinary review of the evidence regarding substance use and harms in people who cycle through prisons and jails. Grounded in solid evidence and a human rights framework, the text provides a roadmap for evidence-based reform
In most countries, problematic drug use is dealt with primarily as a criminal justice issue, rather than a health issue. Accordingly, a large proportion of people in prison have a history of alcohol, tobacco and/or illicit drug use and, despite the best efforts of correctional authorities, some continue to use these substances in prison, often in very risky ways. After release from prison, many relapse to risky substance use, and are at high risk of poor health outcomes, preventable death, or reincarceration. In this edited volume, for the first time we bring together 40 contributors from 10 countries to review what is known about alcohol, tobacco and illicit drug use in people who cycle through prisons, and the harms associated with use of these substances. We consider some evidence-based responses to these harms - both in prison and after return to the community - and discuss their implications for policy reform. This book is international in scope and multi-disciplinary in character. It brings together and integrates the perspectives of public health and addictions researchers, criminologists and correctional leaders, epidemiologists, physicians, and human rights lawyers. Our contributors are unified in their commitment to evidence-informed policy - that is, doing what we know works. An overarching theme pervading all of the chapters is that people who cycle through prisons come from the community, and almost always return to the community. Their health problems are therefore our health problems; in other words, 'prisoner health is public health'.
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
This book reports on research on and experience with needle exchange and bleach distribution programs and their effects on rates of drug use, the behavior of injection drug users, and the spread of HIV and other infectious diseases among injection drug users. It discusses U.S. needle exchange data, international evaluations of needle exchange programs, legal issues and drug paraphernalia laws, evaluation methods, and bleach distribution programs.